http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103690782-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8969 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-618 |
| filingDate | 2013-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103690782-B |
| titleOfInvention | A kind of Chinese medicine composition, preparation method and quality determining method for the treatment of climacteric syndrome |
| abstract | The invention discloses a kind of Chinese medicine composition, its preparation method and quality determining method for the treatment of climacteric syndrome, it is made up of the component of following weight portion: Fructus Ligustri Lucidi 25-45 part, Rhizoma Polygonati 10-20 part, Fructus Corni 10-20 part, Fructus Lycii 10-20 part Herba Ecliptae 10-20 part, Radix Polygoni Multiflori Preparata 13-23 part, Rhizoma Coptidis 5-15 part, Rhizoma Anemarrhenae 10-22 part, Os Draconis 10-22 part, Concha Ostreae 5-14 part, Semen Aesculi 8-18 part, Fructus Citri Sarcodactylis 5-15 part, Radix Scrophulariae 5-15 part, Fructus Citri 6-18 part, Cortex Albiziae 5-14 part.Preparation method is scientific and reasonable.Quality standard comprises the method differentiating Fructus Lycii, Rhizoma Coptidis, the Rhizoma Anemarrhenae, and oleanolic acid is carried out to the method for assay.Pharmacodynamics test achieves good result of the test, and toxicological test shows that clinical plan dosage is safe, is a kind of safe and effective medicine for the treatment of climacteric syndrome, have the rule for the treatment of accurate, novel formula, effect is with strong points, clinical efficacy is definite, without obvious toxic-side effects feature. |
| priorityDate | 2013-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 135.